11459173Vermijlen D, Froelich CJ, Luo D, Suarez-Huerta N, Robaye B, Wisse ECancer immunology, immunotherapy : CIIApoptosis; Colonic Neoplasms; Membrane Glycoproteins; Serine EndopeptidasesBenzimidazoles; Caspase 3; Caspases; DNA, Neoplasm; Drug Resistance, Neoplasm; Fas Ligand Protein; Granzymes; Humans; Perforin; Pore Forming Cytotoxic Proteins; Propidium; Tumor Cells, CulturedPerforin and granzyme B induce apoptosis in FasL-resistant colon carcinoma cells. Cancer Immunol Immunother. 2001 Jun; 50(4):212-7.Cancer Immunol Immunother2001-06-01T00:00:002001Perforin and granzyme B induce apoptosis in FasL-resistant colon carcinoma cells.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD001562Chemicals & Drugs731400.892666BenzimidazolesD003110Disorders1595540.707532Colonic NeoplasmsD004273Chemicals & Drugs1122650.914206DNA, NeoplasmD008562Chemicals & Drugs1894280.823137Membrane GlycoproteinsAuthorship 192292D006801Living Beings2262862810.130052HumansD019008Physiology1805890.751116Drug Resistance, NeoplasmD020169Chemicals & Drugs761550.951373CaspasesD014407Anatomy28110400.85267Tumor Cells, Cultured0.05139340.05139341authors10.2516has subject areaD017209Physiology41016780.608637ApoptosisD053148Chemicals & Drugs901590.955719Caspase 3D053222Chemicals & Drugs36490.984526Fas Ligand ProteinD053804Chemicals & Drugs19920.970294GranzymesD052899Chemicals & Drugs19540.978747Pore Forming Cytotoxic ProteinsD054353Chemicals & Drugs15550.974777PerforinD011419Chemicals & Drugs470.997646PropidiumD012697Chemicals & Drugs671450.930415Serine EndopeptidasesUniversity of ChicagoChristopherFroelichChristopher Froelich41.78927490000000-87.601250000000001210Froelich, Christophertrue1